Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=incyLatest Financial News for Incyte Corporationen-usThu, 24 Dec 2009 09:01:36 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13nce2eld/*http%3A//seekingalpha.com/article/179699-lilly-prepares-for-patent-loss-in-psychosis-drug-moves-into-arthritis-market?source=yahooyahoo_finance/4087344842Thu, 24 Dec 2009 09:01:36 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13097kc62/*http%3A//seekingalpha.com/article/179696-pharma-spreads-holiday-cheer-in-bevy-of-biotech-deals?source=yahooyahoo_finance/632351400Thu, 24 Dec 2009 08:54:17 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/blog/rss/SIG=11h9nc9cc/*http%3A//www.cnbc.com/id/34579621/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/3921469252Thu, 24 Dec 2009 00:51:40 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091222/28592.html?.v=1INCY has entered into a deal with Eli Lilly regarding one of its pipeline candidates.yahoo_finance/4127648080Tue, 22 Dec 2009 20:26:54 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12v0k266q/*http%3A//www.fool.com/investing/general/2009/12/22/some-incyte-into-why-these-drugs-rock.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2205869435Tue, 22 Dec 2009 18:16:07 Etc/GMThttp://us.rd.yahoo.com/finance/external/ft/rss/SIG=125h44q6d/*http%3A//www.ft.com/cms/s/c294d17e-ee34-11de-a274-00144feab49a.html?referrer_id=yahoofinance&ft_ref=yahoo1&segid=03058An upgrade to Alcoa and a flurry of deal activity helped lift US stocks higher on Monday. Analysts at Morgan Stanley raised Alcoa, the country's largest aluminium producer, from "equal weight" to "overweight", saying they expected a rally in aluminium prices to continue into the first half of next year.yahoo_finance/303611780Mon, 21 Dec 2009 21:45:17 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091221/incy8-k.htmlyahoo_finance/2225107444Mon, 21 Dec 2009 21:13:40 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/blog/rss/SIG=11h8d26df/*http%3A//www.cnbc.com/id/34511350/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/1387609668Mon, 21 Dec 2009 18:13:38 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh57699_2009-12-21_17-21-54_sge5bk0f3_newsml&rpc=44&type=marketsNewsyahoo_finance/4128971977Mon, 21 Dec 2009 17:21:54 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091221/us_incyte_mover.html?.v=1Shares of Incyte Corp. jumped Monday after the company struck a development deal with Eli Lilly & Co. potentially worth up to $665 million for inflammatory and autoimmune condition treatments.yahoo_finance/2029505877Mon, 21 Dec 2009 16:56:31 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091221/2661_id.html?.v=1Some big names got into the action on Monday.yahoo_finance/4129327475Mon, 21 Dec 2009 15:17:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/xbarronsblog/rss/SIG=12tcm0ia7/*http%3A//blogs.barrons.com/stockstowatchtoday/2009/12/21/incyte-jumps-5-on-pact-with-lilly/?mod=yahoobarronsyahoo_finance/3046767644Mon, 21 Dec 2009 14:42:43 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11kitjnkn/*http%3A//www.marketwatch.com/News/Story/Story.aspx?guid=%7b4242CAFC-8F1A-4B9C-A1E6-E52E38DEC819%7d&siteid=yhoof2yahoo_finance/1102537219Mon, 21 Dec 2009 14:21:22 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091221/us_eli_lilly_incyte_contract.html?.v=2Eli Lilly & Co. and Incyte Corp. said Monday they will develop a potential treatment for inflammatory and autoimmune diseases in a deal valued at $90 million upfront and potentially worth up to $665 million.yahoo_finance/2787525073Mon, 21 Dec 2009 13:52:24 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12rk29dhs/*http%3A//www.thestreet.com/_yahoo/story/10650162/1/incyte-licenses-drug-to-eli-lilly.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/2519633281Mon, 21 Dec 2009 13:18:37 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091221/20091221005409.html?.v=1WILMINGTON, Del.----Incyte Corporation announced today that it has scheduled a conference call for 8:30 a.m. ET on Monday, December 21, 2009. Conference Call: December 21, 2009 at 8:30 a.m.yahoo_finance/605791961Mon, 21 Dec 2009 12:33:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091221/de28650.html?.v=1Eli Lilly and Company and Incyte Corporation announced today that they have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of Incyte's oral JAK1/JAK2 inhibitor, INCB28050, and certain follow on compounds, for inflammatory and autoimmune diseases.yahoo_finance/3727041372Mon, 21 Dec 2009 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12vacqm7s/*http%3A//www.thestreet.com/_yahoo/story/10648181/1/amazoncom-analysts-upgrades-dowgrades.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/832989586Thu, 17 Dec 2009 13:59:08 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12segk0ce/*http%3A//www.thestreet.com/_yahoo/story/10648181/1/amazon-analysts-upgrades-dowgrades.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/708622325Thu, 17 Dec 2009 13:59:08 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091212/20091212005009.html?.v=1WILMINGTON, Del.----Incyte Corporation announced today positive results from an ongoing Phase I/II clinical trial for its selective oral sheddase inhibitor, INCB7839, involving 46 patients with HER2 positive metastatic breast cancer.yahoo_finance/3625914869Sat, 12 Dec 2009 13:00:00 Etc/GMT